I. Juhan‐Vague

20.2k citations

230 papers · 15.2k indexed · 2 hit papers · h-index 70

Hematology top 0.1%
- Blood Coagulation and Thrombosis Mechanisms 79
Internal Medicine top 0.2%
- Venous Thromboembolism Diagnosis and Management 16
Cancer Research top 0.2%
- Protease and Inhibitor Mechanisms 72
Endocrinology, Diabetes and Metabolism top 0.2%
- Diabetes, Cardiovascular Risks, and Lipoproteins 25
Cardiology and Cardiovascular Medicine top 0.5%
- Acute Myocardial Infarction Research 13
Pulmonary and Respiratory Medicine
- Blood properties and coagulation 61
Epidemiology
- Adipokines, Inflammation, and Metabolic Diseases 57
Immunology and Allergy
- Cell Adhesion Molecules Research 15

Co-authors: Marie‐Christine Alessi Pierre‐Emmanuel Morange P Vague Franck Peiretti Paul Declerck Gilles Nalbone M.F. Aillaud Désiré Collen
Cited by: Hematology Internal Medicine Cancer Research
Journals: Journal of Biological Chemistry (2 papers)Circulation (5 papers)Journal of Clinical Investigation (1 paper)
Partner nations: France Belgium United Kingdom

In The Last Decade

I. Juhan‐Vague

228 papers receiving 14.6k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by I. Juhan‐Vague

Since Specialization

Citations

This map shows the geographic impact of I. Juhan‐Vague's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Juhan‐Vague with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Juhan‐Vague more than expected).

Fields of papers citing papers by I. Juhan‐Vague

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. Juhan‐Vague. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Juhan‐Vague. The network helps show where I. Juhan‐Vague may publish in the future.

Co-authorship network

The 25 scholars most cited alongside I. Juhan‐Vague, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with I. Juhan‐Vague Line = papers co-authored together I. Juhan‐Vague links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	p38 Mitogen Activated Protein Kinase Controls Two Successive-Steps During the Early Mesodermal Commitment of Embryonic Stem Cells Stem Cells and Development ·Emilie Barruet,Ola Hadadeh,Franck Peiretti,Valérie M. Renault,Yasmine Hadjal,Denis Bernot,Roselyne Tournaire,Didier Négre,I. Juhan‐Vague,Marie‐Christine Alessi,Bernard Binétruy	2010	22
2	Prothrombin G20210A carriers the genetic mutation and a history of venous thrombosis contributes to thrombin generation independently of factor II plasma levels Journal of Thrombosis and Haemostasis ·Géraldine Lavigne-Lissalde,Carlos Sánchez,Christel Castelli,Sandrine Alonso,E. Mazoyer,Claire Bal dit Sollier,Ludovic Drouet,I. Juhan‐Vague,Jean‐Christophe Gris,Marie‐Christine Alessi,Pierre‐Emmanuel Morange	2010	21
3	Abstract 1026: Systemic Chemokines Levels and Incident Coronary Heart Disease and Ischemic Stroke Events in Asymptomatic Middle-aged Men: The Prime Study Circulation ·Florence Canouï‐Poitrine,Hospices Civils de Lyon,Gérald Luc,Emeline Machez,Annie Bingham,Jean Ferrières,Jean‐Bernard Ruidavets,Michèle Montaye,John Yarnell,Bernadette Haas,Dominique Arveiler,Pierre‐Emmanuel Morange,I. Juhan‐Vague,Frank Kee,Alun Evans,Philippe Amouyel,Pierre Ducimetière,Jean‐Philippe Empana	2009	1
4	Polymorphisms of the lamina maturation pathway and their association with the metabolic syndrome: the DESIR prospective study Journal of Molecular Medicine ·Bénédicte Fontaine‐Bisson,Marie‐Christine Alessi,Noémie Saut,Frédéric Fumeron,Michel Marre,Anne Dutour,Catherine Badens,Nicolas Lévy,Jean Tichet,I. Juhan‐Vague,David‐Alexandre Trégouët,B. Balkau,Pierre‐Emmanuel Morange	2009	4
5	Metabolic syndrome, haemostasis and thrombosis Thrombosis and Haemostasis ·I. Juhan‐Vague,Marie‐Christine Alessi	2008	136
6	Chronic plasminogen activator inhibitor‐1 (PAI‐1) overexpression dampens CD25+ lymphocyte recruitment after lipopolysaccharide endotoxemia in mouse lung Journal of Thrombosis and Haemostasis ·Marjorie Poggi,Odile Paulmyer‐Lacroix,Monique Verdier,Franck Peiretti,Delphine Bastelica,José Boucraut,H.R. Lijnen,I. Juhan‐Vague,Marie‐Christine Alessi	2007	14
7	Prognostic value of plasma tissue factor and tissue factor pathway inhibitor for cardiovascular death in patients with coronary artery disease: the AtheroGene study Journal of Thrombosis and Haemostasis ·Pierre‐Emmanuel Morange,Stefan Blankenberg,Marie‐Christine Alessi,Christoph Bickel,H. J. Rupprecht,Renate B. Schnabel,Edith Lubos,Thomas Münzel,D Peetz,Viviane Nicaud,I. Juhan‐Vague,Laurence Tiret	2007	56
8	TGF-β1 Released from Activated Platelets Can Induce TNF-Stimulated Human Brain Endothelium Apoptosis: A New Mechanism for Microvascular Lesion during Cerebral Malaria The Journal of Immunology ·Samuel C. Wassmer,J. Brian de Souza,Corinne Frère,Francisco J. Candal,I. Juhan‐Vague,Georges E. Grau	2006	80
9	On the role of plasminogen activator inhibitor‐1 in adipose tissue development and insulin resistance in mice Journal of Thrombosis and Haemostasis ·H.R. Lijnen,Marie‐Christine Alessi,B. Van Hoef,D Collen,I. Juhan‐Vague	2005	56
10	Plasma cystatin-C and development of coronary heart disease: The PRIME Study Atherosclerosis ·Gérald Luc,Jean‐Marie Bard,Céline Lesueur,Dominique Arveiler,Alun Evans,Philippe Amouyel,Jean Ferrières,I. Juhan‐Vague,Jean‐Charles Fruchart,Pierre Ducimetière	2005	92
11	Substances produites par le tissu adipeux, obésité et risque vasculaire La Presse Médicale ·Marie‐Christine Alessi,Corinne Frère,I. Juhan‐Vague	2005	1
12	Du fibrinogène à la fibrine et sa dissolution Bulletin de l Académie Nationale de Médecine ·I. Juhan‐Vague,Michel Hans	2003	1
13	A new mutation, S1285F, within the A1 loop of von Willebrand factor induces a conformational change in A1 loop with abnormal binding to platelet GPIb and botrocetin causing type 2M von Willebrand disease British Journal of Haematology ·Alain Stépanian,Anne‐Sophie Ribba,Jean‐Maurice Lavergne,Édith Fressinaud,I. Juhan‐Vague,Claudine Mazurier,Jean‐Pierre Girma,Dominique Meyer	2003	15
14	Plasma fibrinogen explains much of the difference in risk of coronary heart disease between France and Northern Ireland. The PRIME study Atherosclerosis ·Pierre‐Yves Scarabin,Dominique Arveiler,Philippe Amouyel,Carla Dos Santos,Alun Evans,Gérald Luc,Jean Ferrières,I. Juhan‐Vague	2002	48
15	The insulin resistance syndrome: implications for thrombosis and cardiovascular disease Pathophysiology of Haemostasis and Thrombosis ·I. Juhan‐Vague,Pierre‐Emmanuel Morange,Marie‐Christine Alessi	2002	58
16	Influence of PAI-1 on adipose tissue growth and on metabolic parameters in a murine model of diet-induced obesity Thrombosis and Haemostasis ·Pierre‐Emmanuel Morange,Roger Lijnen,Marie‐Christine Alessi,F Koop,Désiré Collen,I. Juhan‐Vague	1999	2
17	Fibrinolytic function and coronary risk Current Cardiology Reports ·I. Juhan‐Vague,Pierre‐Emmanuel Morange,Marie‐Christine Alessi	1999	27
18	TAFI : lien moléculaire entre les processus de coagulation et de fibrinolyse Sang thrombose vaisseaux ·I. Juhan‐Vague,Marie‐Christine Alessi	1998	0
19	Fibrinogen, fibrinolysis and diabetes mellitus: a comment Diabetologia ·P Vague,I. Juhan‐Vague	1997	21
20	Antiphospholipids in hemodialysis patients: Relationship between lupus anticoagulant and thrombosis Kidney International ·Philippe Brunet,Marie‐Françoise Aillaud,Marielle San Marco,C Philip-Joet,B. Dussol,Dominique Bernard,I. Juhan‐Vague,Yvon Berland	1995	80

About I. Juhan‐Vague

I. Juhan‐Vague is a scholar working on Hematology, Cancer Research and Internal Medicine, having authored 230 papers that have together received 15.2k indexed citations. Recurring topics across this work include Blood Coagulation and Thrombosis Mechanisms (79 papers), Protease and Inhibitor Mechanisms (72 papers), Blood properties and coagulation (61 papers), Adipokines, Inflammation, and Metabolic Diseases (57 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (25 papers), Venous Thromboembolism Diagnosis and Management (16 papers), Cell Adhesion Molecules Research (15 papers) and Acute Myocardial Infarction Research (13 papers). The work is most often cited by research in Hematology (4.2k citations), Internal Medicine (1.2k citations) and Cancer Research (3.4k citations). I. Juhan‐Vague has collaborated with scholars based in France, Belgium and United Kingdom. Frequent co-authors include Marie‐Christine Alessi, Pierre‐Emmanuel Morange, P Vague, P Vague, Franck Peiretti, Paul Declerck, Gilles Nalbone, M.F. Aillaud, Désiré Collen and Jørgen Jespersen. Their work appears in journals such as Journal of Biological Chemistry, Circulation and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact